2019 Klebsiella pneumoniae Infections R&D Pipeline Drugs, Companies, Trials and Developments
The global demand for Klebsiella pneumoniae Infections treatment options is expected to report strong growth over the medium to long term future driven by consumption in major markets. Strong growth prospects of drugs for Klebsiella pneumoniae Infections are driving leading companies to invest their resources on the pipeline.
Companies quickly advancing their drug candidates to advanced phases will evolve as top performers. However, challenges of completing clinical trials on schedules and inadequate financial support are holding some of the Klebsiella pneumoniae Infections pipeline companies from advancing their products.
Klebsiella pneumoniae Infections Report Description
The H1-2019 pipeline review report on Klebsiella pneumoniae Infections is a comprehensive study on drug candidates across different phases worldwide. This report evaluates each of the pipeline products in terms of their current status, regulatory progress and expected phase completion date.
The Klebsiella pneumoniae Infections pipeline guide presents information on all active drugs currently being developed for Klebsiella pneumoniae Infections. The research work provides details of active therapeutic candidates in different phases including discovery, research, pre-clinical, phase I, Phase II, Phase III and pre-registration phases.
Details of current status, R&D progress and latest developments for every Klebsiella pneumoniae Infections pipeline candidate are analyzed.
Further, current phase of development, mechanism of action, special designations such as orphan drug status, fast track designation, grants awarded, etc are presented for all Klebsiella pneumoniae Infections drug candidates.
Drug development companies, collaborators, originating companies, license providers and universities participating in the Klebsiella pneumoniae Infections product pipeline are provided. Company overview, snapshot and developments are provided for all participating companies.
The report assists in identifying potential upcoming companies and drugs in Klebsiella pneumoniae Infections pipeline market along with progress of each drug. It also enables users to formulate effective strategies to stay ahead of competition.
The publisher has developed the report based on robust methodology for assessing pharmaceutical drugs, market sizes and sound forecast tools. All our research reports are provided through intense and repetitive primary and secondary research methods. The report is presented in a user-friendly format and presents clear and actionable insights.
Scope of Klebsiella pneumoniae Infections pipeline report includes-
Companies quickly advancing their drug candidates to advanced phases will evolve as top performers. However, challenges of completing clinical trials on schedules and inadequate financial support are holding some of the Klebsiella pneumoniae Infections pipeline companies from advancing their products.
Klebsiella pneumoniae Infections Report Description
The H1-2019 pipeline review report on Klebsiella pneumoniae Infections is a comprehensive study on drug candidates across different phases worldwide. This report evaluates each of the pipeline products in terms of their current status, regulatory progress and expected phase completion date.
The Klebsiella pneumoniae Infections pipeline guide presents information on all active drugs currently being developed for Klebsiella pneumoniae Infections. The research work provides details of active therapeutic candidates in different phases including discovery, research, pre-clinical, phase I, Phase II, Phase III and pre-registration phases.
Details of current status, R&D progress and latest developments for every Klebsiella pneumoniae Infections pipeline candidate are analyzed.
Further, current phase of development, mechanism of action, special designations such as orphan drug status, fast track designation, grants awarded, etc are presented for all Klebsiella pneumoniae Infections drug candidates.
Drug development companies, collaborators, originating companies, license providers and universities participating in the Klebsiella pneumoniae Infections product pipeline are provided. Company overview, snapshot and developments are provided for all participating companies.
The report assists in identifying potential upcoming companies and drugs in Klebsiella pneumoniae Infections pipeline market along with progress of each drug. It also enables users to formulate effective strategies to stay ahead of competition.
The publisher has developed the report based on robust methodology for assessing pharmaceutical drugs, market sizes and sound forecast tools. All our research reports are provided through intense and repetitive primary and secondary research methods. The report is presented in a user-friendly format and presents clear and actionable insights.
Scope of Klebsiella pneumoniae Infections pipeline report includes-
- Snapshot of pipeline detailing number of active compounds, mergers and acquisitions, phase wise compounds, target areas, mechanism of action, trials etc
- Phase wise pipeline compounds
- Company wise list of pipeline compounds
- Mechanism of Action wise pipeline compounds
- For each pipeline product, the following details are provided-
- Snapshot (Drug, , Phase, Co Developer, Originator, Synonym, Orphan Drug Status, Type of Molecular Entity, Area)
- Current status of development
- Drug overview
- Mechanism of Action
- Pre-clinical and Clinical Trials
- The report is designed to help industry executives promote the success and continued growth of their organizations
- Get clear understanding of the entire Klebsiella pneumoniae Infections pipeline, with details on active projects
- Stay ahead of the competition through comprehensive knowledge of Klebsiella pneumoniae Infections pipeline progress
- Get in detail information of each product with updated information on each project along with key milestones
- Gain clear insights into the market through in-depth strategic analysis review
- Know the list of companies participating in global Klebsiella pneumoniae Infections pipeline along with progress of each of the company’s products and information on associations/collaborations/licensing data
- Get trial information for each pipeline product under development
- Understand the pipeline structure in terms of mechanism of Action, phase and company
GLOBAL KLEBSIELLA PNEUMONIAE INFECTIONS PIPELINE OVERVIEW
Key Findings, 2019
Disease Overview
Report Guide and Research Methodology
EXECUTIVE SUMMARY
Klebsiella pneumoniae Infections Drugs under active development, H1@2019
Pipeline Drugs in Early Stage of Development (Pre-clinical, Discovery, Phase 1 and Phase 2)
Pipeline Drugs in Advanced Stage of Development (Phase 3, Pre-registration)
Companies involved in Klebsiella pneumoniae Infections pipeline, H1@2019
Mechanism of Action wise Klebsiella pneumoniae Infections Pipeline Candidates
ABAC THERAPEUTICS SA KLEBSIELLA PNEUMONIAE INFECTIONS PIPELINE DETAILS
Business Profile
Drug Details
Drug Snapshot
Originator
Collaborator/Co-Developer
Route of Administration
Orphan Drug/Fast Track/Special Designation
Area
Type of Molecular Entity
Current Status
Drug Overview
Drug Mechanism of Action
Clinical/Pre-clinical Trial Details
Latest Drug Developments
ABGENTIS LTD KLEBSIELLA PNEUMONIAE INFECTIONS PIPELINE DETAILS
Business Profile
Drug Details
Drug Snapshot
Originator
Collaborator/Co-Developer
Route of Administration
Orphan Drug/Fast Track/Special Designation
Area
Type of Molecular Entity
Current Status
Drug Overview
Drug Mechanism of Action
Clinical/Pre-clinical Trial Details
Latest Drug Developments
AMPLIPHI BIOSCIENCES CORP KLEBSIELLA PNEUMONIAE INFECTIONS PIPELINE DETAILS
Business Profile
Drug Details
Drug Snapshot
Originator
Collaborator/Co-Developer
Route of Administration
Orphan Drug/Fast Track/Special Designation
Area
Type of Molecular Entity
Current Status
Drug Overview
Drug Mechanism of Action
Clinical/Pre-clinical Trial Details
Latest Drug Developments
APPILI THERAPEUTICS INC KLEBSIELLA PNEUMONIAE INFECTIONS PIPELINE DETAILS
Business Profile
Drug Details
Drug Snapshot
Originator
Collaborator/Co-Developer
Route of Administration
Orphan Drug/Fast Track/Special Designation
Area
Type of Molecular Entity
Current Status
Drug Overview
Drug Mechanism of Action
Clinical/Pre-clinical Trial Details
Latest Drug Developments
ARSANIS INC KLEBSIELLA PNEUMONIAE INFECTIONS PIPELINE DETAILS
Business Profile
Drug Details
Drug Snapshot
Originator
Collaborator/Co-Developer
Route of Administration
Orphan Drug/Fast Track/Special Designation
Area
Type of Molecular Entity
Current Status
Drug Overview
Drug Mechanism of Action
Clinical/Pre-clinical Trial Details
Latest Drug Developments
BB200 LLC KLEBSIELLA PNEUMONIAE INFECTIONS PIPELINE DETAILS
Business Profile
Drug Details
Drug Snapshot
Originator
Collaborator/Co-Developer
Route of Administration
Orphan Drug/Fast Track/Special Designation
Area
Type of Molecular Entity
Current Status
Drug Overview
Drug Mechanism of Action
Clinical/Pre-clinical Trial Details
Latest Drug Developments
C3J THERAPEUTICS INC KLEBSIELLA PNEUMONIAE INFECTIONS PIPELINE DETAILS
Business Profile
Drug Details
Drug Snapshot
Originator
Collaborator/Co-Developer
Route of Administration
Orphan Drug/Fast Track/Special Designation
Area
Type of Molecular Entity
Current Status
Drug Overview
Drug Mechanism of Action
Clinical/Pre-clinical Trial Details
Latest Drug Developments
CONTRAFECT CORP KLEBSIELLA PNEUMONIAE INFECTIONS PIPELINE DETAILS
Business Profile
Drug Details
Drug Snapshot
Originator
Collaborator/Co-Developer
Route of Administration
Orphan Drug/Fast Track/Special Designation
Area
Type of Molecular Entity
Current Status
Drug Overview
Drug Mechanism of Action
Clinical/Pre-clinical Trial Details
Latest Drug Developments
DAIICHI SANKYO CO LTD KLEBSIELLA PNEUMONIAE INFECTIONS PIPELINE DETAILS
Business Profile
Drug Details
Drug Snapshot
Originator
Collaborator/Co-Developer
Route of Administration
Orphan Drug/Fast Track/Special Designation
Area
Type of Molecular Entity
Current Status
Drug Overview
Drug Mechanism of Action
Clinical/Pre-clinical Trial Details
Latest Drug Developments
DEBIOPHARM INTERNATIONAL SA KLEBSIELLA PNEUMONIAE INFECTIONS PIPELINE DETAILS
Business Profile
Drug Details
Drug Snapshot
Originator
Collaborator/Co-Developer
Route of Administration
Orphan Drug/Fast Track/Special Designation
Area
Type of Molecular Entity
Current Status
Drug Overview
Drug Mechanism of Action
Clinical/Pre-clinical Trial Details
Latest Drug Developments
ENBIOTIX INC KLEBSIELLA PNEUMONIAE INFECTIONS PIPELINE DETAILS
Business Profile
Drug Details
Drug Snapshot
Originator
Collaborator/Co-Developer
Route of Administration
Orphan Drug/Fast Track/Special Designation
Area
Type of Molecular Entity
Current Status
Drug Overview
Drug Mechanism of Action
Clinical/Pre-clinical Trial Details
Latest Drug Developments
EVAXION BIOTECH APS KLEBSIELLA PNEUMONIAE INFECTIONS PIPELINE DETAILS
Business Profile
Drug Details
Drug Snapshot
Originator
Collaborator/Co-Developer
Route of Administration
Orphan Drug/Fast Track/Special Designation
Area
Type of Molecular Entity
Current Status
Drug Overview
Drug Mechanism of Action
Clinical/Pre-clinical Trial Details
Latest Drug Developments
F. HOFFMANN-LA ROCHE LTD KLEBSIELLA PNEUMONIAE INFECTIONS PIPELINE DETAILS
Business Profile
Drug Details
Drug Snapshot
Originator
Collaborator/Co-Developer
Route of Administration
Orphan Drug/Fast Track/Special Designation
Area
Type of Molecular Entity
Current Status
Drug Overview
Drug Mechanism of Action
Clinical/Pre-clinical Trial Details
Latest Drug Developments
FEDORA PHARMACEUTICALS INC KLEBSIELLA PNEUMONIAE INFECTIONS PIPELINE DETAILS
Business Profile
Drug Details
Drug Snapshot
Originator
Collaborator/Co-Developer
Route of Administration
Orphan Drug/Fast Track/Special Designation
Area
Type of Molecular Entity
Current Status
Drug Overview
Drug Mechanism of Action
Clinical/Pre-clinical Trial Details
Latest Drug Developments
FORGE THERAPEUTICS INC KLEBSIELLA PNEUMONIAE INFECTIONS PIPELINE DETAILS
Business Profile
Drug Details
Drug Snapshot
Originator
Collaborator/Co-Developer
Route of Administration
Orphan Drug/Fast Track/Special Designation
Area
Type of Molecular Entity
Current Status
Drug Overview
Drug Mechanism of Action
Clinical/Pre-clinical Trial Details
Latest Drug Developments
KYORIN PHARMACEUTICAL CO LTD KLEBSIELLA PNEUMONIAE INFECTIONS PIPELINE DETAILS
Business Profile
Drug Details
Drug Snapshot
Originator
Collaborator/Co-Developer
Route of Administration
Orphan Drug/Fast Track/Special Designation
Area
Type of Molecular Entity
Current Status
Drug Overview
Drug Mechanism of Action
Clinical/Pre-clinical Trial Details
Latest Drug Developments
LEGOCHEM BIOSCIENCES INC KLEBSIELLA PNEUMONIAE INFECTIONS PIPELINE DETAILS
Business Profile
Drug Details
Drug Snapshot
Originator
Collaborator/Co-Developer
Route of Administration
Orphan Drug/Fast Track/Special Designation
Area
Type of Molecular Entity
Current Status
Drug Overview
Drug Mechanism of Action
Clinical/Pre-clinical Trial Details
Latest Drug Developments
MELINTA THERAPEUTICS INC KLEBSIELLA PNEUMONIAE INFECTIONS PIPELINE DETAILS
Business Profile
Drug Details
Drug Snapshot
Originator
Collaborator/Co-Developer
Route of Administration
Orphan Drug/Fast Track/Special Designation
Area
Type of Molecular Entity
Current Status
Drug Overview
Drug Mechanism of Action
Clinical/Pre-clinical Trial Details
Latest Drug Developments
MICROBIOTIX INC KLEBSIELLA PNEUMONIAE INFECTIONS PIPELINE DETAILS
Business Profile
Drug Details
Drug Snapshot
Originator
Collaborator/Co-Developer
Route of Administration
Orphan Drug/Fast Track/Special Designation
Area
Type of Molecular Entity
Current Status
Drug Overview
Drug Mechanism of Action
Clinical/Pre-clinical Trial Details
Latest Drug Developments
NEOCULI PTY LTD KLEBSIELLA PNEUMONIAE INFECTIONS PIPELINE DETAILS
Business Profile
Drug Details
Drug Snapshot
Originator
Collaborator/Co-Developer
Route of Administration
Orphan Drug/Fast Track/Special Designation
Area
Type of Molecular Entity
Current Status
Drug Overview
Drug Mechanism of Action
Clinical/Pre-clinical Trial Details
Latest Drug Developments
NOSOPHARM SAS KLEBSIELLA PNEUMONIAE INFECTIONS PIPELINE DETAILS
Business Profile
Drug Details
Drug Snapshot
Originator
Collaborator/Co-Developer
Route of Administration
Orphan Drug/Fast Track/Special Designation
Area
Type of Molecular Entity
Current Status
Drug Overview
Drug Mechanism of Action
Clinical/Pre-clinical Trial Details
Latest Drug Developments
ORYN THERAPEUTICS KLEBSIELLA PNEUMONIAE INFECTIONS PIPELINE DETAILS
Business Profile
Drug Details
Drug Snapshot
Originator
Collaborator/Co-Developer
Route of Administration
Orphan Drug/Fast Track/Special Designation
Area
Type of Molecular Entity
Current Status
Drug Overview
Drug Mechanism of Action
Clinical/Pre-clinical Trial Details
Latest Drug Developments
PHICO THERAPEUTICS LTD KLEBSIELLA PNEUMONIAE INFECTIONS PIPELINE DETAILS
Business Profile
Drug Details
Drug Snapshot
Originator
Collaborator/Co-Developer
Route of Administration
Orphan Drug/Fast Track/Special Designation
Area
Type of Molecular Entity
Current Status
Drug Overview
Drug Mechanism of Action
Clinical/Pre-clinical Trial Details
Latest Drug Developments
SHIONOGI & CO LTD KLEBSIELLA PNEUMONIAE INFECTIONS PIPELINE DETAILS
Business Profile
Drug Details
Drug Snapshot
Originator
Collaborator/Co-Developer
Route of Administration
Orphan Drug/Fast Track/Special Designation
Area
Type of Molecular Entity
Current Status
Drug Overview
Drug Mechanism of Action
Clinical/Pre-clinical Trial Details
Latest Drug Developments
SOLIGENIX INC KLEBSIELLA PNEUMONIAE INFECTIONS PIPELINE DETAILS
Business Profile
Drug Details
Drug Snapshot
Originator
Collaborator/Co-Developer
Route of Administration
Orphan Drug/Fast Track/Special Designation
Area
Type of Molecular Entity
Current Status
Drug Overview
Drug Mechanism of Action
Clinical/Pre-clinical Trial Details
Latest Drug Developments
SPERO THERAPEUTICS INC KLEBSIELLA PNEUMONIAE INFECTIONS PIPELINE DETAILS
Business Profile
Drug Details
Drug Snapshot
Originator
Collaborator/Co-Developer
Route of Administration
Orphan Drug/Fast Track/Special Designation
Area
Type of Molecular Entity
Current Status
Drug Overview
Drug Mechanism of Action
Clinical/Pre-clinical Trial Details
Latest Drug Developments
SYNTIRON LLC KLEBSIELLA PNEUMONIAE INFECTIONS PIPELINE DETAILS
Business Profile
Drug Details
Drug Snapshot
Originator
Collaborator/Co-Developer
Route of Administration
Orphan Drug/Fast Track/Special Designation
Area
Type of Molecular Entity
Current Status
Drug Overview
Drug Mechanism of Action
Clinical/Pre-clinical Trial Details
Latest Drug Developments
TETRAPHASE PHARMACEUTICALS INC KLEBSIELLA PNEUMONIAE INFECTIONS PIPELINE DETAILS
Business Profile
Drug Details
Drug Snapshot
Originator
Collaborator/Co-Developer
Route of Administration
Orphan Drug/Fast Track/Special Designation
Area
Type of Molecular Entity
Current Status
Drug Overview
Drug Mechanism of Action
Clinical/Pre-clinical Trial Details
Latest Drug Developments
VAXDYN SL KLEBSIELLA PNEUMONIAE INFECTIONS PIPELINE DETAILS
Business Profile
Drug Details
Drug Snapshot
Originator
Collaborator/Co-Developer
Route of Administration
Orphan Drug/Fast Track/Special Designation
Area
Type of Molecular Entity
Current Status
Drug Overview
Drug Mechanism of Action
Clinical/Pre-clinical Trial Details
Latest Drug Developments
VAXXILON AG KLEBSIELLA PNEUMONIAE INFECTIONS PIPELINE DETAILS
Business Profile
Drug Details
Drug Snapshot
Originator
Collaborator/Co-Developer
Route of Administration
Orphan Drug/Fast Track/Special Designation
Area
Type of Molecular Entity
Current Status
Drug Overview
Drug Mechanism of Action
Clinical/Pre-clinical Trial Details
Latest Drug Developments
LATEST KLEBSIELLA PNEUMONIAE INFECTIONS DRUG PIPELINE DEVELOPMENTS, 2019
APPENDIX
About Us
Sources and Methodology
Contact Information
Key Findings, 2019
Disease Overview
Report Guide and Research Methodology
EXECUTIVE SUMMARY
Klebsiella pneumoniae Infections Drugs under active development, H1@2019
Pipeline Drugs in Early Stage of Development (Pre-clinical, Discovery, Phase 1 and Phase 2)
Pipeline Drugs in Advanced Stage of Development (Phase 3, Pre-registration)
Companies involved in Klebsiella pneumoniae Infections pipeline, H1@2019
Mechanism of Action wise Klebsiella pneumoniae Infections Pipeline Candidates
ABAC THERAPEUTICS SA KLEBSIELLA PNEUMONIAE INFECTIONS PIPELINE DETAILS
Business Profile
Drug Details
Drug Snapshot
Originator
Collaborator/Co-Developer
Route of Administration
Orphan Drug/Fast Track/Special Designation
Area
Type of Molecular Entity
Current Status
Drug Overview
Drug Mechanism of Action
Clinical/Pre-clinical Trial Details
Latest Drug Developments
ABGENTIS LTD KLEBSIELLA PNEUMONIAE INFECTIONS PIPELINE DETAILS
Business Profile
Drug Details
Drug Snapshot
Originator
Collaborator/Co-Developer
Route of Administration
Orphan Drug/Fast Track/Special Designation
Area
Type of Molecular Entity
Current Status
Drug Overview
Drug Mechanism of Action
Clinical/Pre-clinical Trial Details
Latest Drug Developments
AMPLIPHI BIOSCIENCES CORP KLEBSIELLA PNEUMONIAE INFECTIONS PIPELINE DETAILS
Business Profile
Drug Details
Drug Snapshot
Originator
Collaborator/Co-Developer
Route of Administration
Orphan Drug/Fast Track/Special Designation
Area
Type of Molecular Entity
Current Status
Drug Overview
Drug Mechanism of Action
Clinical/Pre-clinical Trial Details
Latest Drug Developments
APPILI THERAPEUTICS INC KLEBSIELLA PNEUMONIAE INFECTIONS PIPELINE DETAILS
Business Profile
Drug Details
Drug Snapshot
Originator
Collaborator/Co-Developer
Route of Administration
Orphan Drug/Fast Track/Special Designation
Area
Type of Molecular Entity
Current Status
Drug Overview
Drug Mechanism of Action
Clinical/Pre-clinical Trial Details
Latest Drug Developments
ARSANIS INC KLEBSIELLA PNEUMONIAE INFECTIONS PIPELINE DETAILS
Business Profile
Drug Details
Drug Snapshot
Originator
Collaborator/Co-Developer
Route of Administration
Orphan Drug/Fast Track/Special Designation
Area
Type of Molecular Entity
Current Status
Drug Overview
Drug Mechanism of Action
Clinical/Pre-clinical Trial Details
Latest Drug Developments
BB200 LLC KLEBSIELLA PNEUMONIAE INFECTIONS PIPELINE DETAILS
Business Profile
Drug Details
Drug Snapshot
Originator
Collaborator/Co-Developer
Route of Administration
Orphan Drug/Fast Track/Special Designation
Area
Type of Molecular Entity
Current Status
Drug Overview
Drug Mechanism of Action
Clinical/Pre-clinical Trial Details
Latest Drug Developments
C3J THERAPEUTICS INC KLEBSIELLA PNEUMONIAE INFECTIONS PIPELINE DETAILS
Business Profile
Drug Details
Drug Snapshot
Originator
Collaborator/Co-Developer
Route of Administration
Orphan Drug/Fast Track/Special Designation
Area
Type of Molecular Entity
Current Status
Drug Overview
Drug Mechanism of Action
Clinical/Pre-clinical Trial Details
Latest Drug Developments
CONTRAFECT CORP KLEBSIELLA PNEUMONIAE INFECTIONS PIPELINE DETAILS
Business Profile
Drug Details
Drug Snapshot
Originator
Collaborator/Co-Developer
Route of Administration
Orphan Drug/Fast Track/Special Designation
Area
Type of Molecular Entity
Current Status
Drug Overview
Drug Mechanism of Action
Clinical/Pre-clinical Trial Details
Latest Drug Developments
DAIICHI SANKYO CO LTD KLEBSIELLA PNEUMONIAE INFECTIONS PIPELINE DETAILS
Business Profile
Drug Details
Drug Snapshot
Originator
Collaborator/Co-Developer
Route of Administration
Orphan Drug/Fast Track/Special Designation
Area
Type of Molecular Entity
Current Status
Drug Overview
Drug Mechanism of Action
Clinical/Pre-clinical Trial Details
Latest Drug Developments
DEBIOPHARM INTERNATIONAL SA KLEBSIELLA PNEUMONIAE INFECTIONS PIPELINE DETAILS
Business Profile
Drug Details
Drug Snapshot
Originator
Collaborator/Co-Developer
Route of Administration
Orphan Drug/Fast Track/Special Designation
Area
Type of Molecular Entity
Current Status
Drug Overview
Drug Mechanism of Action
Clinical/Pre-clinical Trial Details
Latest Drug Developments
ENBIOTIX INC KLEBSIELLA PNEUMONIAE INFECTIONS PIPELINE DETAILS
Business Profile
Drug Details
Drug Snapshot
Originator
Collaborator/Co-Developer
Route of Administration
Orphan Drug/Fast Track/Special Designation
Area
Type of Molecular Entity
Current Status
Drug Overview
Drug Mechanism of Action
Clinical/Pre-clinical Trial Details
Latest Drug Developments
EVAXION BIOTECH APS KLEBSIELLA PNEUMONIAE INFECTIONS PIPELINE DETAILS
Business Profile
Drug Details
Drug Snapshot
Originator
Collaborator/Co-Developer
Route of Administration
Orphan Drug/Fast Track/Special Designation
Area
Type of Molecular Entity
Current Status
Drug Overview
Drug Mechanism of Action
Clinical/Pre-clinical Trial Details
Latest Drug Developments
F. HOFFMANN-LA ROCHE LTD KLEBSIELLA PNEUMONIAE INFECTIONS PIPELINE DETAILS
Business Profile
Drug Details
Drug Snapshot
Originator
Collaborator/Co-Developer
Route of Administration
Orphan Drug/Fast Track/Special Designation
Area
Type of Molecular Entity
Current Status
Drug Overview
Drug Mechanism of Action
Clinical/Pre-clinical Trial Details
Latest Drug Developments
FEDORA PHARMACEUTICALS INC KLEBSIELLA PNEUMONIAE INFECTIONS PIPELINE DETAILS
Business Profile
Drug Details
Drug Snapshot
Originator
Collaborator/Co-Developer
Route of Administration
Orphan Drug/Fast Track/Special Designation
Area
Type of Molecular Entity
Current Status
Drug Overview
Drug Mechanism of Action
Clinical/Pre-clinical Trial Details
Latest Drug Developments
FORGE THERAPEUTICS INC KLEBSIELLA PNEUMONIAE INFECTIONS PIPELINE DETAILS
Business Profile
Drug Details
Drug Snapshot
Originator
Collaborator/Co-Developer
Route of Administration
Orphan Drug/Fast Track/Special Designation
Area
Type of Molecular Entity
Current Status
Drug Overview
Drug Mechanism of Action
Clinical/Pre-clinical Trial Details
Latest Drug Developments
KYORIN PHARMACEUTICAL CO LTD KLEBSIELLA PNEUMONIAE INFECTIONS PIPELINE DETAILS
Business Profile
Drug Details
Drug Snapshot
Originator
Collaborator/Co-Developer
Route of Administration
Orphan Drug/Fast Track/Special Designation
Area
Type of Molecular Entity
Current Status
Drug Overview
Drug Mechanism of Action
Clinical/Pre-clinical Trial Details
Latest Drug Developments
LEGOCHEM BIOSCIENCES INC KLEBSIELLA PNEUMONIAE INFECTIONS PIPELINE DETAILS
Business Profile
Drug Details
Drug Snapshot
Originator
Collaborator/Co-Developer
Route of Administration
Orphan Drug/Fast Track/Special Designation
Area
Type of Molecular Entity
Current Status
Drug Overview
Drug Mechanism of Action
Clinical/Pre-clinical Trial Details
Latest Drug Developments
MELINTA THERAPEUTICS INC KLEBSIELLA PNEUMONIAE INFECTIONS PIPELINE DETAILS
Business Profile
Drug Details
Drug Snapshot
Originator
Collaborator/Co-Developer
Route of Administration
Orphan Drug/Fast Track/Special Designation
Area
Type of Molecular Entity
Current Status
Drug Overview
Drug Mechanism of Action
Clinical/Pre-clinical Trial Details
Latest Drug Developments
MICROBIOTIX INC KLEBSIELLA PNEUMONIAE INFECTIONS PIPELINE DETAILS
Business Profile
Drug Details
Drug Snapshot
Originator
Collaborator/Co-Developer
Route of Administration
Orphan Drug/Fast Track/Special Designation
Area
Type of Molecular Entity
Current Status
Drug Overview
Drug Mechanism of Action
Clinical/Pre-clinical Trial Details
Latest Drug Developments
NEOCULI PTY LTD KLEBSIELLA PNEUMONIAE INFECTIONS PIPELINE DETAILS
Business Profile
Drug Details
Drug Snapshot
Originator
Collaborator/Co-Developer
Route of Administration
Orphan Drug/Fast Track/Special Designation
Area
Type of Molecular Entity
Current Status
Drug Overview
Drug Mechanism of Action
Clinical/Pre-clinical Trial Details
Latest Drug Developments
NOSOPHARM SAS KLEBSIELLA PNEUMONIAE INFECTIONS PIPELINE DETAILS
Business Profile
Drug Details
Drug Snapshot
Originator
Collaborator/Co-Developer
Route of Administration
Orphan Drug/Fast Track/Special Designation
Area
Type of Molecular Entity
Current Status
Drug Overview
Drug Mechanism of Action
Clinical/Pre-clinical Trial Details
Latest Drug Developments
ORYN THERAPEUTICS KLEBSIELLA PNEUMONIAE INFECTIONS PIPELINE DETAILS
Business Profile
Drug Details
Drug Snapshot
Originator
Collaborator/Co-Developer
Route of Administration
Orphan Drug/Fast Track/Special Designation
Area
Type of Molecular Entity
Current Status
Drug Overview
Drug Mechanism of Action
Clinical/Pre-clinical Trial Details
Latest Drug Developments
PHICO THERAPEUTICS LTD KLEBSIELLA PNEUMONIAE INFECTIONS PIPELINE DETAILS
Business Profile
Drug Details
Drug Snapshot
Originator
Collaborator/Co-Developer
Route of Administration
Orphan Drug/Fast Track/Special Designation
Area
Type of Molecular Entity
Current Status
Drug Overview
Drug Mechanism of Action
Clinical/Pre-clinical Trial Details
Latest Drug Developments
SHIONOGI & CO LTD KLEBSIELLA PNEUMONIAE INFECTIONS PIPELINE DETAILS
Business Profile
Drug Details
Drug Snapshot
Originator
Collaborator/Co-Developer
Route of Administration
Orphan Drug/Fast Track/Special Designation
Area
Type of Molecular Entity
Current Status
Drug Overview
Drug Mechanism of Action
Clinical/Pre-clinical Trial Details
Latest Drug Developments
SOLIGENIX INC KLEBSIELLA PNEUMONIAE INFECTIONS PIPELINE DETAILS
Business Profile
Drug Details
Drug Snapshot
Originator
Collaborator/Co-Developer
Route of Administration
Orphan Drug/Fast Track/Special Designation
Area
Type of Molecular Entity
Current Status
Drug Overview
Drug Mechanism of Action
Clinical/Pre-clinical Trial Details
Latest Drug Developments
SPERO THERAPEUTICS INC KLEBSIELLA PNEUMONIAE INFECTIONS PIPELINE DETAILS
Business Profile
Drug Details
Drug Snapshot
Originator
Collaborator/Co-Developer
Route of Administration
Orphan Drug/Fast Track/Special Designation
Area
Type of Molecular Entity
Current Status
Drug Overview
Drug Mechanism of Action
Clinical/Pre-clinical Trial Details
Latest Drug Developments
SYNTIRON LLC KLEBSIELLA PNEUMONIAE INFECTIONS PIPELINE DETAILS
Business Profile
Drug Details
Drug Snapshot
Originator
Collaborator/Co-Developer
Route of Administration
Orphan Drug/Fast Track/Special Designation
Area
Type of Molecular Entity
Current Status
Drug Overview
Drug Mechanism of Action
Clinical/Pre-clinical Trial Details
Latest Drug Developments
TETRAPHASE PHARMACEUTICALS INC KLEBSIELLA PNEUMONIAE INFECTIONS PIPELINE DETAILS
Business Profile
Drug Details
Drug Snapshot
Originator
Collaborator/Co-Developer
Route of Administration
Orphan Drug/Fast Track/Special Designation
Area
Type of Molecular Entity
Current Status
Drug Overview
Drug Mechanism of Action
Clinical/Pre-clinical Trial Details
Latest Drug Developments
VAXDYN SL KLEBSIELLA PNEUMONIAE INFECTIONS PIPELINE DETAILS
Business Profile
Drug Details
Drug Snapshot
Originator
Collaborator/Co-Developer
Route of Administration
Orphan Drug/Fast Track/Special Designation
Area
Type of Molecular Entity
Current Status
Drug Overview
Drug Mechanism of Action
Clinical/Pre-clinical Trial Details
Latest Drug Developments
VAXXILON AG KLEBSIELLA PNEUMONIAE INFECTIONS PIPELINE DETAILS
Business Profile
Drug Details
Drug Snapshot
Originator
Collaborator/Co-Developer
Route of Administration
Orphan Drug/Fast Track/Special Designation
Area
Type of Molecular Entity
Current Status
Drug Overview
Drug Mechanism of Action
Clinical/Pre-clinical Trial Details
Latest Drug Developments
LATEST KLEBSIELLA PNEUMONIAE INFECTIONS DRUG PIPELINE DEVELOPMENTS, 2019
APPENDIX
About Us
Sources and Methodology
Contact Information
